Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. [electronic resource]
Producer: 20070329Description: 436-47 p. digitalISSN:- 1462-8902
- Adolescent
- Adult
- Aged
- Blood Glucose -- metabolism
- Blood Pressure
- Body Weight -- drug effects
- Cardiovascular Diseases -- etiology
- Diabetes Mellitus, Type 2 -- blood
- Diabetic Angiopathies -- blood
- Double-Blind Method
- Drug Therapy, Combination
- Exenatide
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- adverse effects
- Lipids -- blood
- Male
- Metformin -- therapeutic use
- Middle Aged
- Overweight
- Peptides -- adverse effects
- Risk Factors
- Sulfonylurea Compounds -- therapeutic use
- Venoms -- adverse effects
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.